Foreign Drugs Welcome As China Reforms Progress: CFDA Commissioner

China’s drug regulators have had plenty of views to offer at recent major government congress sessions in Beijing, which provide a forum for the industry to meet officials and opportunities to outline reform progress and planned policies.

Chinese flag

In a bid to shed more light on the activities and positive changes at the China FDA, the agency’s commissioner Bi Jingquan appears to be willing to speak at every possible opportunity during the week-long Lianghui (Two Sessions) annual plenary People’s Congress and Political Consultative Congress meetings that have been taking place in Beijing.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from China

More from Asia